LNG exporter Venture Global slashes IPO price range

LNG exporter Venture Global raises $1.75 billion in US IPO
(Reuters) -Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial public offering of President Donald Trump's second term as investors bet on his plan to boost U.
Venture Global Slashes IPO Price Range by More Than 40%
Venture Global Inc. slashed the marketed range for its initial public offering, bringing the potential valuation well below its $110 billion target.
LNG exporter Venture Global slashes IPO price range despite President Trump’s pro-energy push
Venture Global is now seeking a more reasonable valuation of about $65 billion, versus earlier plans for about $110 billion.
LNG exporter Venture Global cuts target valuation for US IPO to $65.3 billion
Venture Global LNG on Wednesday slashed the valuation it sought from a U.S. initial public offering to $65.33 billion, significantly lower than the initial target of $110 billion.
Venture Global LNG Raises $1.75 Billion in IPO Amid Adjusted Valuation
Venture Global LNG has successfully raised $1.75 billion through its U.S. IPO after pricing 70 million shares at $25 each. The offering was adjusted from an initial plan of 50 million shares priced at $40 to $46 to
LNG exporter Venture Global slashes IPO valuation target by $45B after investors balk
Liquefied natural gas producer Venture Global slashed the proposed range for its IPO on Wednesday, lowering the valuation it sought to ~$65B from the initial target of $110B at the top of the previous range.
LNG exporter Venture Global raises $1.75 bln in US IPO
Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial public offering of President Donald Trump's second term as investors bet on his plan to boost U.
Trump Partner Builds $1 Billion Stake From India Real Estate IPO
When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...
FierceBiotech2h
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...
ANG.PR.D: A 7.375% Preferred Shares IPO From American National Group
Financial analysis of American National Group's preferred stock ANG-D reveals concerns about dividend payments and market ...
Gulfbusiness.com on MSN14m
Saudi Arabia’s Derayah Financial plans to sell 20% stake in Riyadh IPO
The brokerage is offering 49.94 million shares, representing 20 per cent of the company’s total issued share capital ...
Arabian Business1h
Derayah announces IPO, set to list on Saudi Exchange with 20% share offering
Derayah got the Saudi market regulator Capital Market Authority’s nod in December for the sale of 49,947,039 ordinary shares, ...
inc422h
Exclusive: Capillary Technologies To File DRHP For $200 Mn IPO By June
Capillary Technologies has restarted the preparations for its IPO and is likely to file the IPO papers for a $200 Mn public ...
Aardvark Therapeutics Files for IPO
Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...
Rockville's Ascentage Pharma seeks to raise $134M in U.S. IPO
A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.
The Financial Express5h
Dr. Agarwal’s Healthcare IPO: 11 key points to know before subscribing
Discover key points about Dr. Agarwal's Healthcare IPO, opening Jan 29. Assess risks, investment details, and market buzz.